Login / Signup

Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.

Xiao-Wen HuangYang HuangLi-da ChenZhu WangZheng YangJin-Ya LiuXiao-Yan XieMing-De LuShun-Li ShenWei Wang
Published in: Journal of medical ultrasonics (2001) (2017)
The combination of enhancement patterns on CEUS and serum tumor markers (AFP and CA19-9) may be a potentially specific diagnostic method to differentiate CHC from HCC and CC.
Keyphrases
  • contrast enhanced ultrasound
  • magnetic resonance imaging
  • magnetic resonance
  • risk assessment